Get the Stockscreener App
539.40
0.42%
2.2562
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Chemed Corp stock is traded at $539.40, with a volume of 51,131.
It is up +0.42% in the last 24 hours and up +10.39% over the past month.
Chemed Corp purchases, operates, and divests subsidiaries engaged in diverse business activities to maximize shareholder value. The company operates in the following segments: VITAS and Roto-Rooter. The VITAS segment generates the majority of the firm's revenue and provides hospice and palliative care services to patients with terminal illnesses through a network of physicians, registered nurses, home health aides, social workers, and volunteers. The Roto-Rooter segment provides plumbing, drain cleaning, water restoration, and related services to residential and commercial customers.
See More
Previous Close:
$537.14
Open:
$530.56
24h Volume:
51,131
Relative Volume:
0.27
Market Cap:
$7.04B
Revenue:
$2.54B
Net Income/Loss:
$259.78M
P/E Ratio:
29.40
EPS:
18.3497
Net Cash Flow:
$377.12M
1W Performance:
-1.31%
1M Performance:
+10.39%
6M Performance:
+16.26%
1Y Performance:
+21.72%
1-Day Range:
$527.32
$540.02
1-Week Range:
$527.32
$557.00
52-Week Range:
$365.20
$557.00
Chemed Corp Stock (CHE) Company Profile
Name
Chemed Corp
Sector
Industry
Phone
(513)762-6690
Address
SUITE 2600, CINCINNATI, OH
Compare CHE vs HCA, THC, FMS, EHC, DVA
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CHE
Chemed Corp
|
538.82 | 7.02B | 2.54B | 259.78M | 377.12M | 18.35 |
HCA
Hca Healthcare Inc
|
410.88 | 89.08B | 76.39B | 7.81B | 7.93B | 29.08 |
THC
Tenet Healthcare Corp
|
264.09 | 20.89B | 21.46B | 2.65B | 3.35B | 19.23 |
FMS
Fresenius Medical Care Ag Adr
|
23.62 | 12.70B | 22.44B | 1.35B | 2.03B | 1.9002 |
EHC
Encompass Health Corp
|
124.34 | 12.37B | 6.07B | 793.80M | 464.40M | 5.9914 |
DVA
Davita Inc
|
179.09 | 11.38B | 13.84B | 1.10B | 1.49B | 10.42 |
Chemed Corp Stock (CHE) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-27-26 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Jan-22-26 | Downgrade | Jefferies | Buy → Hold |
| Sep-02-25 | Upgrade | Jefferies | Hold → Buy |
| Jul-25-25 | Initiated | Jefferies | Hold |
| Mar-11-20 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Nov-01-19 | Upgrade | JMP Securities | Mkt Perform → Mkt Outperform |
| Sep-06-19 | Reiterated | BofA/Merrill | Buy |
| Oct-12-18 | Initiated | BofA/Merrill | Buy |
| Aug-28-17 | Initiated | KeyBanc Capital Mkts | Sector Weight |
| Nov-01-16 | Reiterated | RBC Capital Mkts | Sector Perform |
| Jul-27-16 | Reiterated | RBC Capital Mkts | Sector Perform |
| May-02-16 | Reiterated | RBC Capital Mkts | Sector Perform |
| Oct-26-15 | Reiterated | Oppenheimer | Outperform |
| Oct-26-15 | Reiterated | RBC Capital Mkts | Sector Perform |
| Sep-22-15 | Reiterated | Oppenheimer | Outperform |
| Jul-27-15 | Reiterated | RBC Capital Mkts | Sector Perform |
| Feb-19-15 | Reiterated | Oppenheimer | Outperform |
| Sep-23-14 | Reiterated | Oppenheimer | Outperform |
| Jun-10-14 | Reiterated | RBC Capital Mkts | Sector Perform |
| May-01-14 | Reiterated | Oppenheimer | Outperform |
| Sep-10-13 | Reiterated | Deutsche Bank | Hold |
| Mar-04-11 | Reiterated | Barclays Capital | Underweight |
| Feb-17-11 | Reiterated | Oppenheimer | Outperform |
| Feb-17-11 | Reiterated | RBC Capital Mkts | Sector Perform |
View All
Chemed Corp Stock (CHE) Latest News
Royal Bank of Canada Sells 18,419 Shares of Chemed Corporation $CHE - MarketBeat
Chemed Corp VP Brian C. Judkins Executes Stock Option Exercise and Sells Shares on August 10, 2026 - Kalkine Media
Chemed Corp (CHE) legal chief exercises 6,786 options, withholds 5,878 shares - Stock Titan
Chemed Corp (CHE) Stock Analysis: Navigating High Valuation with Sustainable Growth Potential - DirectorsTalk Interviews
Chemed Corporation $CHE Shares Sold by Quantinno Capital Management LP - MarketBeat
Chemed Corp stock hits 52-week high at 552.05 USD By Investing.com - Investing.com India
Understanding Momentum Shifts in (CHE) - Stock Traders Daily
Chemed Corp stock hits 52-week high at 552.05 USD - Investing.com
Chemed Corporation (NYSE:CHE) to Issue Dividend Increase$0.70 Per Share - MarketBeat
Chemed Corp (CHE) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Chemed Corp (CHE) Stock News Today - TradingKey
Chemed Corp (NYSE: CHE) executive exercises 2,599 options, 2,270 shares withheld - Stock Titan
What Drove Chemed (NYSE:CHE) Higher After Quarterly Report? - Kalkine Media
Chemed Corporation Declares Quarterly Dividend of 70 Cents - finance.yahoo.com
Chemed (NYSE:CHE) Hits New 52-Week HighTime to Buy? - MarketBeat
California State Teachers Retirement System Increases Stock Position in Chemed Corporation $CHE - MarketBeat
Chemed Corp (CHE) Stock Forecasts - finance.yahoo.com
Chemed Corporation: Why A Spin-Off Could Unlock Its Hidden Value (NYSE:CHE) - Seeking Alpha
Amundi Raises Stock Position in Chemed Corporation $CHE - MarketBeat
Chemed Corp (CHE) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Insider Selling: Chemed (NYSE:CHE) CEO Sells $1,079,020.00 in Stock - MarketBeat
Chemed (NYSE: CHE) CEO sells 2,000 shares after exercising stock options - Stock Titan
Chemed Corporation’s Record 24,000-Patient Census Sustains VITAS’ Growth Surge! - Smartkarma
Chemed director Patrick Grace sells $101,080 in company stock - Investing.com
Form 4 Chemed Corp For: 3 August By Investing.com - Investing.com Australia
Chemed director Patrick Grace sells $101,080 in company stock By Investing.com - Investing.com Canada
Chemed (NYSE: CHE) director sells 190 shares at $532 in open trade - Stock Titan
Chemed Corp (CHE) Stock Analysis: Evaluating Growth Potential with a Strong Market Position - DirectorsTalk Interviews
Chemed (NYSE:CHE) Director Sells 190 Shares - MarketBeat
CHE Q2 Deep Dive: VITAS Growth and Roto-Rooter Marketing Pressures Shape Outlook - finance.yahoo.com
CHE: Q2 2026 saw strong VITAS growth and stable Roto-Rooter margins, prompting raised guidance - TradingView
BofA raises Chemed stock price target to $550 on Vitas outlook - Investing.com Nigeria
Chemed Q2 Earnings Call Highlights - MarketBeat
Chemed Corp reports results for the quarter ended June 30Earnings Summary - TradingView
Chemed earnings up next: Can VITAS momentum sustain premium? By Investing.com - Investing.com Nigeria
Chemed earnings up next: Can VITAS momentum sustain premium? - Investing.com
Chemed Corp stock hits 52-week high at 519.04 USD By Investing.com - Investing.com Nigeria
Chemed Corporation $CHE Stock Position Cut by NewEdge Wealth LLC - MarketBeat
Chemed raises FY26 adj EPS guidance to $25.00-$25.75 vs $24.34 estimate - scanx.trade
Chemed Corp (CHE) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Avoiding Lag: Real-Time Signals in (CHE) Movement - Stock Traders Daily
Chemed Corp (CHE) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Chemed Corp (CHE) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Chemed Corp (CHE) Balance Sheet - TradingKey
Chemed Corp (CHE) Cash Flow - TradingKey
Chemed Corp (CHE) Stock Analysis: What Investors Need to Know About This Healthcare Giant’s Potential - DirectorsTalk Interviews
Chemed (CHE) Q2 Earnings: What To Expect - finance.yahoo.com
Why Is Chemed (NYSE:CHE) Expanding Service Reach? - Kalkine Media
TradingKey - TradingKey
Epoch Investment Partners Inc. Sells 72,285 Shares of Chemed Corporation $CHE - MarketBeat
California Public Employees Retirement System Decreases Stock Holdings in Chemed Corporation $CHE - MarketBeat
Chemed Corp Stock (CHE) Financials Data
Revenue
Net Income
Cash Flow
EPS
Chemed Corp Stock (CHE) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Wherley Joel L | CEO - Vitas Healthcare |
Aug 05 '26 |
Option Exercise |
445.35 |
2,599 |
1,157,465 |
3,451 |
| MCNAMARA KEVIN J | president and CEO |
Jul 31 '26 |
Option Exercise |
445.35 |
2,001 |
891,145 |
92,220 |
| MCNAMARA KEVIN J | president and CEO |
Aug 03 '26 |
Sale |
539.51 |
2,000 |
1,079,020 |
70,418 |
2.47%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):